Marktinformationen
- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,970 | 19.07.24 19:51:44 | +1,720 | +1,38% | 125,960 | 125,980 | 125,300 | 124,250 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 101,110 | 19.07.24 19:49:56 | +2,150 | +2,17% | 100,710 | 101,440 | 100,500 | 98,960 |
